147 related articles for article (PubMed ID: 17589536)
1. Graft versus lymphoma effect after early relapse following reduced-intensity sibling allogeneic stem cell transplantation for relapsed cytotoxic variant of mycosis fungoides.
Gabriel IH; Olavarria E; Jones RR; Whittaker S; Chaidos A; Apperley JF
Bone Marrow Transplant; 2007 Aug; 40(4):401-3. PubMed ID: 17589536
[No Abstract] [Full Text] [Related]
2. Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides: evidence of a graft-versus-tumor effect.
Burt RK; Guitart J; Traynor A; Link C; Rosen S; Pandolfino T; Kuzel TM
Bone Marrow Transplant; 2000 Jan; 25(1):111-3. PubMed ID: 10654025
[TBL] [Abstract][Full Text] [Related]
3. Evidence of graft-versus-tumour effect following allogeneic haematopoietic stem cell transplantation in renal cancer other than clear cell type.
Secondino S; Pedrazzoli P; Giannetta L; Schiavetto I; Vanzulli A; Siena S
Bone Marrow Transplant; 2004 Nov; 34(10):917-8. PubMed ID: 15361912
[No Abstract] [Full Text] [Related]
4. Two cases of mycosis fungoides treated by reduced-intensity cord blood transplantation.
Tsuji H; Wada T; Murakami M; Kashiwagi T; Ito Y; Ishida-Yamamoto A; Jimbo J; Shindo M; Sato K; Kohgo Y; Iizuka H
J Dermatol; 2010 Dec; 37(12):1040-5. PubMed ID: 21083707
[TBL] [Abstract][Full Text] [Related]
5. Graft-versus-lymphoma effect in refractory cutaneous T-cell lymphoma after reduced-intensity HLA-matched sibling allogeneic stem cell transplantation.
Herbert KE; Spencer A; Grigg A; Ryan G; McCormack C; Prince HM
Bone Marrow Transplant; 2004 Sep; 34(6):521-5. PubMed ID: 15286686
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning for mycosis fungoides and Sezary syndrome.
Shiratori S; Fujimoto K; Nishimura M; Hatanaka KC; Kosugi-Kanaya M; Okada K; Sugita J; Shigematsu A; Hashimoto D; Endo T; Kondo T; Abe R; Hashino S; Matsuno Y; Shimizu H; Teshima T
Hematol Oncol; 2016 Mar; 34(1):9-16. PubMed ID: 25312300
[TBL] [Abstract][Full Text] [Related]
7. [Progressive multifocal leukoencephalopathy in a patient with acute myeloid leukaemia after allogeneic hematopoietic-cell transplantation].
Fernández-Ruiz M; de la Serna J; Ruiz J; López-Medrano F
Enferm Infecc Microbiol Clin; 2011 Oct; 29(8):636-7. PubMed ID: 21696864
[No Abstract] [Full Text] [Related]
8. Allogeneic stem cell transplantation in first complete remission enhances graft-versus-leukemia effect in adults with acute lymphoblastic leukemia: antileukemic activity of chronic graft-versus-host disease.
Lee S; Cho BS; Kim SY; Choi SM; Lee DG; Eom KS; Kim YJ; Kim HJ; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Shin WS; Kim CC
Biol Blood Marrow Transplant; 2007 Sep; 13(9):1083-94. PubMed ID: 17697971
[TBL] [Abstract][Full Text] [Related]
9. A comparison between low intensity and reduced intensity conditioning in allogeneic hematopoietic stem cell transplantation for solid tumors.
Conrad R; Remberger M; Cederlund K; Ringdén O; Barkholt L
Haematologica; 2008 Feb; 93(2):265-72. PubMed ID: 18245651
[TBL] [Abstract][Full Text] [Related]
10. Graft-versus-adult T-cell leukemia/lymphoma effect following allogeneic hematopoietic stem cell transplantation.
Yonekura K; Utsunomiya A; Takatsuka Y; Takeuchi S; Tashiro Y; Kanzaki T; Kanekura T
Bone Marrow Transplant; 2008 Jun; 41(12):1029-35. PubMed ID: 18332910
[TBL] [Abstract][Full Text] [Related]
11. Progressive multifocal leukoencephalopathy from JC virus in a patient with advanced mycosis fungoides.
Lee J; Richardson SK; Melhem ER; Rook AH; Kim EJ
J Am Acad Dermatol; 2007 Nov; 57(5):893-5. PubMed ID: 17761357
[TBL] [Abstract][Full Text] [Related]
12. High response rate to donor lymphocyte infusion after allogeneic stem cell transplantation for indolent non-Hodgkin lymphoma.
Bloor AJ; Thomson K; Chowdhry N; Verfuerth S; Ings SJ; Chakraverty R; Linch DC; Goldstone AH; Peggs KS; Mackinnon S
Biol Blood Marrow Transplant; 2008 Jan; 14(1):50-8. PubMed ID: 18158961
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic hematopoietic stem cell transplantation for peripheral T cell lymphomas; evidence of graft-versus-T cell lymphoma effect.
Hamadani M; Awan FT; Elder P; Lin TS; Porcu P; Blum KA; Devine SM
Biol Blood Marrow Transplant; 2008 Apr; 14(4):480-3. PubMed ID: 18342792
[No Abstract] [Full Text] [Related]
14. Durable remission of Sézary syndrome after unrelated bone marrow transplantation by reduced-intensity conditioning.
Kahata K; Hashino S; Takahata M; Fujisawa F; Kondo T; Kobayashi S; Fujita Y; Shimizu H; Imamura M; Asaka M
Acta Haematol; 2008; 120(1):14-8. PubMed ID: 18716396
[TBL] [Abstract][Full Text] [Related]
15. Sustained response after reduced-intensity conditioning allogeneic stem cell transplantation for patients with relapsed peripheral T-cell non-Hodgkin lymphoma.
de Lavallade H; Cassier PA; Bouabdallah R; El-Cheikh J; Faucher C; Fürst S; Coso D; Sainty D; Arnoulet C; Gastaut JA; Chetaille B; Xerri L; Blaise D; Mohty M
Br J Haematol; 2008 Sep; 142(5):848-50. PubMed ID: 18631344
[No Abstract] [Full Text] [Related]
16. Progressive multifocal leukoencephalopathy after allogeneic stem cell transplantation and posttransplantation rituximab.
Steurer M; Clausen J; Gotwald T; Gunsilius E; Stockhammer G; Gastl G; Nachbaur D
Transplantation; 2003 Jul; 76(2):435-6. PubMed ID: 12883208
[No Abstract] [Full Text] [Related]
17. Reduced-intensity conditioning compared with conventional allogeneic stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
Sureda A; Robinson S; Canals C; Carella AM; Boogaerts MA; Caballero D; Hunter AE; Kanz L; Slavin S; Cornelissen JJ; Gramatzki M; Niederwieser D; Russell NH; Schmitz N
J Clin Oncol; 2008 Jan; 26(3):455-62. PubMed ID: 18086796
[TBL] [Abstract][Full Text] [Related]
18. Reduced-intensity allogeneic stem cell transplantation for renal cell carcinoma: in vivo evidence of a graft-versus-tumor effect.
Takami A; Asakura H; Koshida K; Namiki M; Nakao S
Haematologica; 2004 Mar; 89(3):375-6. PubMed ID: 15020287
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes following myeloablative allogeneic transplantation for multiple myeloma compared to autologous transplantation and the impact of graft-versus-myeloma effect.
Khaled Y; Mellacheruvu S; Reddy P; Peres E; Mineishi S
Bone Marrow Transplant; 2009 Sep; 44(5):325-6. PubMed ID: 19204708
[No Abstract] [Full Text] [Related]
20. Allogeneic stem cell transplantation is able to induce long-term remissions in angioimmunoblastic T-cell lymphoma: a retrospective study from the lymphoma working party of the European group for blood and marrow transplantation.
Kyriakou C; Canals C; Finke J; Kobbe G; Harousseau JL; Kolb HJ; Novitzky N; Goldstone AH; Sureda A; Schmitz N
J Clin Oncol; 2009 Aug; 27(24):3951-8. PubMed ID: 19620487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
